Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00226421 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain
A Phase 3 study of Chronic Pain, sponsored by Endo Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
- 20
- Study locations
NCT00226421 is a Phase 3 study of Chronic Pain that has completed, run by Endo Pharmaceuticals. The registered enrollment target is 120 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower). The trial reports 20 study locations across 10 states.
The verdict
NCT00226421, a Phase 3 study of Chronic Pain, has completed, sponsored by Endo Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the analgesic efficacy and safety of oxymorphone extended release in opioid-experienced patients with chronic low back pain.
Conditions Studied
Interventions
- DRUG Oxymorphone Extended Release
Study Locations (20)
Florida
- Radiant Research - Daytona Beach
- University Clinical Research - DeLand
- LCFP Inc. - Fort Myers
- Century Clinical Research - Holly Hill
- Ocala Rheumatology Research Center - Ocala
- The Arthritis Center - Palm Harbor
- Radiant Research - Pinellas Park
- Park Place Therapeutic Center - Plantation
Arizona
- Phoenix Center for Clinical Research - Phoenix
- Arizona Research - Phoenix
Georgia
- Comprehensive Neurology Specialists - Atlanta
- Comprehensive Neuroscience - Atlanta
Missouri
- Research Medical Center - Kansas City
- Radiant Research - St Louis
Alabama
- Southern Drug Research - Hueytown
Colorado
- Express Care Clinical Research - Colorado Springs
Delaware
- Glasgow Family Practice - Newark
Illinois
- Pain Specialists of Greater Chicago - Burr Ridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2004-10 |
| Est. Completion | 2005-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00226421
The ClinicalTrials.gov registry entry for NCT00226421 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (84% lower). The listed sponsor is Endo Pharmaceuticals, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Oxymorphone Extended Release is the first listed.
NCT00226421 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Florida, Arizona, Georgia.
Frequently Asked Questions
What is clinical trial NCT00226421 about?
NCT00226421 is a clinical study titled "Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain". The purpose of this study is to evaluate the analgesic efficacy and safety of oxymorphone extended release in opioid-experienced patients with chronic low back pain.
What is the current status of trial NCT00226421?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2004-10. Estimated completion is 2005-08.
What conditions does trial NCT00226421 study?
This clinical trial studies the following conditions: Chronic Pain.
What interventions are being tested in trial NCT00226421?
The interventions under investigation include: Oxymorphone Extended Release (DRUG).
Who is sponsoring clinical trial NCT00226421?
This trial is sponsored by Endo Pharmaceuticals, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00226421 being conducted?
This trial has 20 study locations across Alabama, Arizona, Colorado, Delaware, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
RECRUITING · Phase 3
-
CARES-Spine (Comprehensive Analgesic, Recovery, and Education Support for Spine Surgery) Trial
RECRUITING · Phase 3
-
Nonpharmacologic Pain Management in FQHC Primary Care Clinics
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Digital Therapeutic for Chronic Pain Feasibility Study
COMPLETED · Phase 3
-
An Implantable Spinal Cord Stimulation Pain Management System
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.